- Home
- ZYXI vs UNCY Comparison
ZYXI vs UNCY Comparison
Compare ZYXI & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- UNCY
- Stock Information
- Founded
- ZYXI 1996
- UNCY 2016
- Country
- ZYXI United States
- UNCY United States
- Employees
- ZYXI N/A
- UNCY N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- UNCY Health Care
- Exchange
- ZYXI Nasdaq
- UNCY Nasdaq
- Market Cap
- ZYXI 66.5M
- UNCY 71.3M
- IPO Year
- ZYXI N/A
- UNCY 2021
- Fundamental
- Price
- ZYXI $2.02
- UNCY $0.65
- Analyst Decision
- ZYXI Buy
- UNCY Strong Buy
- Analyst Count
- ZYXI 3
- UNCY 4
- Target Price
- ZYXI $6.00
- UNCY $6.38
- AVG Volume (30 Days)
- ZYXI 176.4K
- UNCY 969.6K
- Earning Date
- ZYXI 07-24-2025
- UNCY 05-14-2025
- Dividend Yield
- ZYXI N/A
- UNCY N/A
- EPS Growth
- ZYXI N/A
- UNCY N/A
- EPS
- ZYXI N/A
- UNCY N/A
- Revenue
- ZYXI $172,401,000.00
- UNCY N/A
- Revenue This Year
- ZYXI N/A
- UNCY N/A
- Revenue Next Year
- ZYXI $19.55
- UNCY $1,422.24
- P/E Ratio
- ZYXI N/A
- UNCY N/A
- Revenue Growth
- ZYXI N/A
- UNCY N/A
- 52 Week Low
- ZYXI $1.66
- UNCY $0.20
- 52 Week High
- ZYXI $10.62
- UNCY $0.96
- Technical
- Relative Strength Index (RSI)
- ZYXI 40.53
- UNCY 49.67
- Support Level
- ZYXI $2.21
- UNCY $0.56
- Resistance Level
- ZYXI $2.66
- UNCY $0.62
- Average True Range (ATR)
- ZYXI 0.20
- UNCY 0.05
- MACD
- ZYXI 0.02
- UNCY 0.00
- Stochastic Oscillator
- ZYXI 5.19
- UNCY 74.83
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.